Nanox is an Israeli medical technology company building an end-to-end medical imaging platform focused on making imaging more accessible and affordable globally. The company's core hardware product is the Nanox.ARC, a 3D digital tomosynthesis imaging system built around a proprietary semiconductor-based X-ray source that replaces the traditional analog X-ray tube. Because the digital source eliminates the need for heat-based electron emission, it removes the cooling equipment and rotating mechanisms that make conventional CT scanners costly and bulky. Nanox argues this results in a system that delivers 3D tomographic imaging at up to 80% less radiation than CT, with a smaller footprint and lower cost, enabling deployment in settings like urgent care centers, orthopedic practices, and skilled nursing facilities. Beyond hardware, Nanox operates three complementary businesses: Nanox.AI, which offers seven FDA-cleared AI algorithms that analyze routine CT scans for early signs of chronic diseases like cardiovascular disease and osteoporosis; USARAD, a teleradiology service connecting imaging facilities to radiologists for remote image interpretation on a per-read fee basis; and Nanox Health IT, a recently acquired healthcare IT services business providing RIS/PACS implementation and managed IT services to U.S. hospitals. Teleradiology is currently the largest and only profitable segment. The Nanox.ARC hardware business is early-stage, with distribution agreements signed for roughly 360 CapEx systems in the U.S., though only a small number are deployed and generating revenue. Nanox sells hardware via outright CapEx sales, a per-scan subscription model, and OEM licensing of its X-ray source technology.